https://www.neurologylive.com/view/rituximab-treatment-associated-reduced-relapse-rate-aqp4-igg-positive-nmosd-mogad
0
0
Rituximab Treatment Associated with Reduced Relapse Rate in AQP4-IgG Positive NMOSD and MOGAD - Neurology Live
10/11/22 at 3:04pm
Organization
Neurologylive.com
Authors
Isabella Ciccone MPH
Details
42 words
Summarize
Health Neurological Conditions Drugs & Medications IGG Rituximab Treatment Associated MOGAD - Neurology Live A patient data Positive NMOSD NMOSD
A study using patient data from John Hopkins showed that rituximab treatment was associated with reduced annualized relapse rates in AQP4-IgG seropositive NMOSD and MOGAD.
Create an account or login to join the discussion